http://www.lsis.com/goto/r93/rss 2010-06-23T11:10:54+01:00 text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FB%1Cuxz OCEANSIDE, Calif.-(BUSINESS WIRE)-International Stem Cell Corporation (OTCBB:ISCO), www.intlstemcell.com, a California-based biotechnology company focused on therapeutic and research products, announced today that Charles J. Casamento was elected to the Board of Directors, on June 21, 2010. Mr. Casamento is a vital addition to our Board and brings to International Stem Cell Corporation expertise in areas that will help guide our company through growth, including corporate governance, business development, strategic planning, financing, mergers and acquisitions, product development, clinical trials and corporate and research and development collaboration activities Mr. Casamento is (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FB%1Cuzr PHILADELPHIA & HARRISBURG, Pa.-(BUSINESS WIRE)-CoventryCares, a Medicaid managed care organization currently serving southeastern Pennsylvania, has partnered with The Maternity Care Coalition and the Healthy Mothers, Healthy Babies (HMHB) Coalition, to launch the Philadelphia text4baby campaign. CoventryCares will use the new program to help educate and encourage the use of the service to its Bright Expectations prenatal program members. Text4baby is a free, mobile information service designed to promote maternal and child health by providing pregnant women and new moms with detailed health tips, via SMS text message, to assist them in caring for themselves and their children. The (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FB%1Cuz%7F DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/31e56f/oral_care_in_usa) has announced the addition of the "Oral Care in USA" report to their offering. Value sales in the US oral care sector declined slightly in 2009, by just under 1%. Due to the economic downturn, consumers became more value-conscious when making purchases. However, sales of value-added products, such as power toothbrushes and battery toothbrushes, saw an increase in 2009, as consumers continued to purchase products that simplified their oral hygiene routine, despite their typically higher unit prices. Americans continue to be concerned about the aesthetics of their teeth and. (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FB%1Cu%7C%7F LOUISVILLE, Colo.-(BUSINESS WIRE)-GHX and its participating suppliers and providers are on target to cut a total of $5 billion in healthcare costs in the next 5 years by improving supply chain efficiencies, visibility and trading partner collaboration. GHX provides technology and services to automate and optimize business processes throughout the healthcare supply chain, and has achieved its first-quarter goal of cutting more than $155.6 million in healthcare costs. For the past 10 years, GHX and its participating healthcare suppliers and providers have focused on cutting billions of dollars in waste from the healthcare supply chain The model GHX is utilizing to measure progress toward (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FB%1Cty%7E RARITAN, N.J.-(BUSINESS WIRE)-Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI) announced today it has signed an exclusive agreement with Diamyd Medical AB, a Swedish publicly traded company focusing on the development of pharmaceuticals for the treatment of autoimmune diabetes and its complications, to develop and commercialize their GAD65 antigen-based therapy for the treatment and prevention of type 1 diabetes and associated conditions. This investigational therapy is currently being evaluated in Phase 3 clinical studies in newly diagnosed type 1 diabetes patients for its ability to delay or prevent progression of the disease and its associated complications by delaying or preventing (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FB%1Ct%7Bz STOCKHOLM-(BUSINESS WIRE)-Diamyd Medical AB (STO:DIAMB)(Pink Sheets:DMYDY) has signed an agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), a Johnson & Johnson company, to develop and commercialize the Diamyd diabetes therapy. This agreement will allow Diamyd to expand and become a significant player as a specialty pharma company in the Nordic region, but most importantly it should make this transformational beta cell preserving therapy available to patients around the world. The agreement relates to the development and world-wide commercialization of the GAD65 antigen-based therapy (Diamyd) for the treatment and prevention of type 1 diabetes and associated conditions. (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v93/%3B%97f%FB%13%7Cxy The pre-clinical characterization of novel aryloxypyridine amides that are histamine H(3) receptor antagonists is described. These compounds are high affinity histamine H(3) ligands that penetrate the CNS and occupy the histamine H(3) receptor in rat brain. Several compounds were extensively profiled pre-clinically leading to the identification of two compounds suitable for nomination as development candidates. |-| Bioorg Med Chem Lett. |-| Letavic MA, Aluisio L, Atack JR, Bonaventure P, Carruthers NI, Dugovic C, Everson A, Feinstein MA, Fraser IC, Hoey K, Jiang X, Keith JM, Koudriakova T, Leung P, Lord B, Lovenberg TW, Ly KS, Morton KL, Timothy Motley S, Nepomuceno D, Rizzolio M, Rynberg (…) text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v93/%3B%97f%FB%10%7Dzs Eight Canadian smokers begin their journey by sharing the emotional and inspirational reasons behind their decision to quit smoking. Tell us why you're ready to quit smoking in a YouTube video entry to be eligible for a chance to win one of sixty NICORETTE Quit Kits filled with over $300 CDN worth of NICORETTE products. TORONTO, ONTARIO-(Marketwire - June 21, 2010) - Editors Note: There are 2 video included with this Press Release. Many Canadians want to quit smoking but struggle to become smoke-free. In fact, a recent Angus Reid Public Opinion survey for NICORETTE indicated three-quarter of smokers (75 per cent) have tried to quit more than once and failed. Now, SMOBER UP", an (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FB%11txx CARY, N.C.-(BUSINESS WIRE)-Publicis Healthcare Communications Group (PHCG), the world's largest healthcare communications group, has received CEO Cancer Gold Standard ¢ accreditation, recognizing the organization s commitment to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment. We are investing in your health because we care about you William C. Weldon, chairman and chief executive officer of Johnson & Johnson, chairs the CEO Roundtable on Cancer, a nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard ¢, (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FB%11t%7C%7B NEEDHAM, Mass.-(BUSINESS WIRE)-Three leading scientists in the field of cardiac safety in pre-clinical drug development are gathering to discuss Improved Strategies for Pre-clinical Cardiac Testing in a free webinar on June 23 at 11:00 a.m. EDT, sponsored by the Drug Safety Council (DSEC). most trusted and most used fee-for-service provider The panel features Arthur œBuzz  Brown, M.D., Ph.D., founder, president and CEO of ChanTest www.chantest.com, David J. Gallacher, BSc., Ph.D. senior director, Center of Excellence for Cardiovascular Safety Research, Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica, Belgium www.jnjpharmarnd.com, and Gary (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FB%14%7E%7Ex ALISO VIEJO, Calif.-(BUSINESS WIRE)-Medical device company Vertos Medical Inc. has announced the expansion of its senior leadership team with the appointment of Randel W. Woodgrift to senior vice president of operations and research and development, and Ann Deren-Lewis to vice president of marketing. With decades of leadership experience in their respective functional areas, Woodgrift and Deren-Lewis have been tapped to support the accelerating U.S. commercialization of Vertos mild* technology for the treatment of lumbar spinal stenosis (LSS). Randy has the proven ability to scale up worldwide medical device operations and develop innovative new products, while Ann has significant (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FB%14%7Dv%7D DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/813005/feminine_care_in_t) has announced the addition of the "Feminine Care in the US to 2014" report to their offering. Feminine Care in the US to 2014 This databook provides key data and information on the feminine care market in the US. This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods. Scope Contains information on four categories; sanitary pads, pantiliners and shields, tampons and internal (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v93/%3B%97f%FC%12%7Bwy Bloomberg - Roche Holding AG, Johnson & Johnson and Biogen Idec Inc. are being urged by U.S. regulators to evaluate their hepatitis, cancer and anemia drugs for less- common ailments, after an incentive program to generate research into new medicines for neglected diseases failed. text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v93/%3B%97f%FC%12zy%7E NEWARK, NJ-(Marketwire - June 17, 2010) - Edge Therapeutics, Inc., a specialty pharmaceutical company focused on improving the delivery of life-saving medicines to the brain, is pleased to announce the appointment of 21 scientific advisory board members and five business advisors. "We are honored to have many of the world's leading experts in stroke and brain injury research participate in our scientific advisory board," said R. Loch Macdonald, MD, PhD, Chief Scientific Officer of Edge Therapeutics and Keenan Endowed Chair of Neurosurgery at St. Michael's Hospital in Toronto. "These individuals, from leading academic institutes around the world, offer tremendous medical and clinical (…) text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v93/%3B%97f%FC%12zxy OneTouch(R) Ultra(R) Blue Test Strips with DoubleSure(TM) Technology To listen to the first audio clip, please click above To listen to the second audio clip, please click above BURNABY, BRITISH COLUMBIA-(Marketwire - June 17, 2010) Editors Note: There is audio and a photo associated with this Press Release. Much of our lives are dictated by numbers from street, phone, salary, social security to mileage most Canadians can recite different numbers in a heartbeat. For the more than three million Canadians living with diabetes (i), numbers are especially important as only their blood sugar readings allow them to really understand what is happening inside their bodies and make decisions to (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FC%12%7E%7Ds FORT WORTH, Texas-(BUSINESS WIRE)-HEALTHPOINT, Ltd., a DFB Pharmaceuticals, Inc. company, has announced Brad Adams has joined the company as Vice President, Sales. Prior to Healthpoint, Mr. Adams achieved international experience in health care sales, marketing and business administration at several Johnson & Johnson affiliate companies. His extensive exposure to and command of every aspect of healthcare business make him a tremendous addition to our team. œI am pleased to welcome Brad on board,  said Travis E. Baugh, President and Chief Operating Officer at Healthpoint. œHis extensive exposure to and command of every aspect of healthcare business make him a tremendous addition to (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FC%12%7D%7Bz LANSDALE, Pa.-(BUSINESS WIRE)-Microsoft Corp. has named Merck and Company, Inc. and ProtonMedia winners of the company s Life Sciences Innovation Awards 2010. The awards, announced at the Drug Information Association s (DIA) 46th annual meeting in Washington, D.C., were given in recognition of innovative solutions in the pharmaceutical and life sciences industry. The awards honor companies that have demonstrated the successful application of available software and devices to revolutionize medicine, bring therapeutic breakthroughs to market faster, fight serious ailments, improve health, and enhance people s quality of life. Microsoft recognized Merck s innovative use of ProtonMedia s (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FC%12%7Dz%7B SAN DIEGO-(BUSINESS WIRE)-Nexus Dx today announced two organizational changes in their Commercial Operations team. Paul Benson steps into the newly created position of Senior Director of Corporate Accounts for North America. Paul will be responsible for extending Nexus Dx customer base and extending market access to Nexus Dx products by securing Group Purchasing Organization (GPO) contracts, developing corporate business-to-business commercial relationships, managing large national accounts and the Nexus Dx business in Canada. Paul most recently was the Senior Director of Sales for North America for the Company. Additionally, Scott has a great background in sales and marketing management (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FC%12%7Cw%7D DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/ba034b/analgesics_in_germ) has announced the addition of the "Analgesics in Germany" report to their offering. In recent years, Germany has seen increasing health awareness and trend towards more health-conscious lifestyles. Rather than relying on medicine to treat the symptoms of illnesses that were developed due to negligent attitudes to the body, Germans are now keen on retaining healthy diets and active lifestyles in an attempt to support their personal health. This has negatively affected demand for analgesics, which are some of the most common and most consumed remedies when treating illnesses. (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v93/%3B%97f%FC%14xxs PURPOSE: To evaluate the use of octyl-2-cyanoacrylate liquid bandage (Band-Aid liquid, Ethicon, Johnson & Johnson, New Jersey, USA) as a temporary treatment in patients awaiting surgical repair for involutional entropion. METHODS: Thirteen patients (15 eyelids) with involutional entropion were evaluated while they waited for surgical intervention. The lids were repositioned by the application of octyl-2-cyanoacrylate liquid bandage in the malar fold. Patients were followed-up at days 1, 7 and 15. Assessment and duration of correction were recorded. RESULTS: All the patients presented successful correction at day 1, with significant improvements in signs and symptoms. The mean duration of (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v93/%3B%97f%FD%1Ct%7E%7B VANCOUVER, BRITISH COLUMBIA-(Marketwire - 06/17/10) - Aquinox Pharmaceuticals Inc., a private, venture-backed, biopharmaceutical company developing novel and targeted small molecule therapeutics for the treatment of inflammatory disease and cancer, announced today that it has secured U.S. $25 million in the close of a Series B financing led by Ventures West Capital. New investor Pfizer Venture Investments (PVI) participated in the financing along with all other existing investors: Johnson & Johnson Development Corporation, Baker Brothers Investments and BC Advantage Funds (VCC) Ltd. Mr. Kenneth Galbraith, General Partner of Ventures West Capital, commented, "We are very pleased to welcome (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v93/%3B%97f%FD%1C%7Bx%7B FORT WORTH, Texas-(BUSINESS WIRE)-HEALTHPOINT, Ltd., a DFB Pharmaceuticals, Inc. company, has announced Brad Adams has joined the company as Vice President, Sales. Prior to Healthpoint, Mr. Adams achieved international experience in health care sales, marketing and business administration at several Johnson & Johnson affiliate companies. text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v93/%3B%97f%FD%1Czwz BASEL, SWITZERLAND-(Marketwire - June 15, 2010) - Basilea Pharmaceutica AG / Basilea announces distribution agreement with Almirall for Toctino in selected European markets and Mexico processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. Basilea Pharmaceutica Ltd. (SWISS: BSLN) announced today that Basilea Pharmaceutica International Ltd. has entered into an exclusive distribution agreement with Almirall, S.A. for Basilea's Toctino (alitretinoin), a once-daily oral treatment for adults with severe chronic hand eczema unresponsive to potent topical corticosteroids, in selected European markets and Mexico. Basilea has appointed (…) text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v93/%3B%97f%FD%1Cz%7B%7D Highlighted Links Blue Chip Patient Recruitment NORTHBROOK, IL-(Marketwire - June 15, 2010) - Blue Chip, an independent, full-service global marketing agency, announced today the launch of Blue Chip Patient Recruitment (BCPR), a division dedicated to serving pharmaceutical and biotech clients with clinical trial recruitment marketing. This new division reflects Blue Chip's 15 years of continued growth in patient recruitment and leverages the resources of a full-service agency with deep expertise in direct response media, retail brand marketing and clinical site recruitment management. BCPR's first client is BioSante Pharmaceuticals, Inc. "We are pleased to launch the new division with a (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FD%1Cx%7C%7B CHAPEL HILL, N.C.-(BUSINESS WIRE)-POZEN Inc. (NASDAQ: POZN), today announced the election of Neal F. Fowler to its Board of Directors at the Annual Meeting of Shareholders held on June 10, 2010. Mr. Fowler is Chief Executive Officer of Liquidia Technologies, Inc. Mr. Fowler joined Liquidia in 2008 after seven successful years at Johnson & Johnson (J&J). While at J&J, Mr. Fowler served as President of Centocor, Inc., a multi-billion dollar subsidiary focused on development and commercialization of industry leading biomedicines used in the treatment of chronic inflammatory diseases. At Centocor, Mr. Fowler prepared the company for the launch of two potential blockbuster products and (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v93/%3B%97f%FD%13uw%7C A pyridazin-4-one fragment 4 (hCatS IC(50)=170muM) discovered through Tethering was modeled into cathepsin S and predicted to overlap in S2 with the tetrahydropyridinepyrazole core of a previously disclosed series of CatS inhibitors. This fragment served as a template to design pyridazin-3-one 12 (hCatS IC(50)=430nM), which also incorporates P3 and P5 binding elements. A crystal structure of 12 bound to Cys25Ser CatS led to the synthesis of the potent diazinone isomers 22 (hCatS IC(50)=60nM) and 27 (hCatS IC(50)=40nM). |-| Bioorg Med Chem Lett. |-| Ameriks MK, Bembenek SD, Burdett MT, Choong IC, Edwards JP, Gebauer D, Gu Y, Karlsson L, Purkey HE, Staker BL, Sun S, Thurmond RL, Zhu J. |-| (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v93/%3B%97f%FD%11tx%7C Aims: Assessment of health related quality-of-life (HRQL) has become increasingly important as not only the clinician's view of the technical success, but also the patient's perception is being measured. We evaluated the HRQL following sirolimus-eluting coronary stent (SES) (CYPHER(R); Cordis, Johnson & Johnson, Warren, NJ, USA) implantation in patients with multivessel disease, comparing the outcomes with the historical surgical and bare metal stent (BMS) arms of the ARTS-I study.Methods and results: The HRQL outcomes were compared to the outcome of the historical cohorts of the randomised ARTS-I trial using the same inclusion and exclusion criteria. HRQL was evaluated at baseline, at one (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v93/%3B%97f%FD%11z%7Cr CHAPEL HILL, N.C.-(BUSINESS WIRE)-POZEN Inc. (NASDAQ: POZN), today announced the election of Neal F. Fowler to its Board of Directors at the Annual Meeting of Shareholders held on June 10, 2010. Mr. Fowler is Chief Executive Officer of Liquidia Technologies, Inc. Mr. Fowler joined Liquidia in 2008 after seven successful years at Johnson & Johnson (J&J). While at J&J, Mr. Fowler served as President of Centocor, Inc., a multi-billion dollar subsidiary focused on development and commercialization of industry leading biomedicines used in the treatment of chronic inflammatory diseases. At Centocor, Mr. Fowler prepared the company for the launch of two potential blockbuster products and (…) text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v93/%3B%97f%FD%11xvs Highlighted Links http:/www.businessgrouphealth.org WASHINGTON, DC-(Marketwire - June 14, 2010) - A record number of U.S. employers were honored today by the National Business Group on Health for their continuing commitment to promoting healthy work environments and encouraging workers to choose healthier lifestyles. A total of 66 large employers, including 13 first-time winners, were presented with "2010 Best Employers for Healthy Lifestyles" awards at the Business Group's Institute on Innovation in Workforce Well-being Leadership Summit held in Washington, DC. "Employers all across the nation are recognizing just how important a healthy workplace and a healthy workforce are to (…) text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v93/%3B%97f%FD%11xv%7F ROCKVILLE, MD-(Marketwire - June 14, 2010) - MarketResearch.com has announced the addition of Kalorama Information's new report "The Global Market for Medical Devices," to their collection of Medical Devices market reports. For more information, visit http:/www.marketresearch.com/product/display.asp?ProductID=2592223. The medical device market is vast and everything from a large imaging system to a disposable item can be classified as a type of medical device. Throughout the past decade, Kalorama has covered many device markets in detail. Certain areas such as infusion pumps, patient monitoring and catheters have shown promising growth. Others have solid market leaders earning stable (…) text/html http://www.medicalnewstoday.com Medical News Today http://www.lsis.com/goto/v93/%3B%97f%FD%11%7Fyr A baseball umpire's broken hip has shed light on doctors' conflicts of interest in recommending certain devices over others and the growth, despite efforts to rein it in, of such practices, Bloomberg Businessweek reports. "The government declared last year that it had overhauled the financial relationships between surgeons and the biggest makers of knees and hips, saying the threat of criminal prosecution for 'kickbacks' had forced them to slash payments to physicians." But compensation for doctors who use the certain knees and hips soon returned. "Prosecutors in the New Jersey U.S. Attorney's Office, which headed the case, reported a 'satisfactory completion' in March 2009 of the probe of (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FD%11%7F%7E%7E LOS ANGELES-(BUSINESS WIRE)-AIDS Healthcare Foundation: Drug spending by ADAPs has increased more than seven-fold (617%) since 1996, more than twice the rate of client growth over this same period. WHAT: PROTEST Re: BMS Pricing of AIDS Drug, Reyataz, one of the most expensive first line AIDS treatments in the US WHEN: TUESDAY, June 15th, 10:00 AM Pacific WHERE: outside the Goldman Sachs Global Healthcare Conference 2010 Hyatt Regency Century Plaza Hotel 2025 Avenue of the Stars Century City, CA VISUALS: 3ft x 6ft œShame on BMS  and œHow do you spell GREED? BMS  banners & placards with image of CEO Andreotti surrounded by Piles of Cash Protestors, marching with signs and chanting (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FD%11%7Ezs DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/c1a00d/global_molecular_d) has announced the addition of the "Global Molecular Diagnostics Market 2009-2013" report to their offering. Molecular Diagnostics is the clinical application of molecular biology technologies, used in disease management. It consists of screening and diagnostics tests - using genetic material (DNA and RNA). Further, the Molecular Diagnostics tests facilitate early diagnosis of a disease, therapeutic efficacy of drugs, genetic predisposition to disease, and prediction of individual's response to drug. Thus, the Molecular Diagnostics technologies offer the potential (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FD%11%7Ezz EMMAUS, Pa.-(BUSINESS WIRE)-Rodale Inc. today announced that Joseph Burke has been appointed Vice President, Green Culture Services, effective immediately. In this role, Burke will oversee and direct the performance of Rodale s Facilities Management, Office Services, Food Services, and the Employee Fitness Center to ensure that all operations function in the most organic and environmentally responsible manner possible consistent with Rodale s vision and mission. Burke will work closely with senior management and across multiple departments to proactively identify and pursue initiatives that continue to reduce Rodale s carbon footprint and will collaborate with external business partners (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FD%11%7E%7Dy DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/b2fd5c/medical_devices_ma) has announced the addition of the "Medical Devices Market in China 2009-2013" report to their offering. Medical devices comprise surgical equipment & appliances, diagnostic devices, X-ray, ophthalmic equipment, laboratory devices & diagnostics, dental equipment, medical disposables and others. The Chinese Medical devices industry is experiencing healthcare reforms leading to improvisation and increase in demand for new improved medical devices. The Chinese government is taking various initiatives to provide improved and sustainable healthcare to its citizen by expanding its (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v93/%3B%97f%FD%15xz%7C We have recently completed the synthesis of 1-[2-(4-cyclobutyl-[1,4]diazepane-1-carbonyl)-4-(3-fluoro-phenoxy)-pyrrolidin-1-yl]-ethanone, a hydroxyproline-based H(3) receptor antagonist, on 100 g scale. The synthesis proceeds through four steps and route selection was driven by a desire to minimize the cost-of-goods. Naturally occurring trans-4-hydroxy-L-proline was chosen as the precursor to the target's core, which necessitated an inversion at both stereogenic centers. The inversions were accomplished through strategic employment of La Rosa's lactone and a late-stage Mitsunobu reaction. A first generation synthesis that employed N-Boc-homopiperazine was improved in a second generation (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v93/%3B%97f%FD%15%7F%7Ds Mol Interv. |-| Flores CM, Vasko MR. |-| Johnson & Johnson Pharmaceutical Research & Development, LLC, Titusville, NJ 08560. text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FE%1Cuv%7D DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/aff927/global_in_vitro_di) has announced the addition of the "Global In Vitro Diagnostics Market 2009-2013" report to their offering. Innovations and advancement in various In Vitro Diagnostics (IVD) technologies (including molecular biology, immunoassays, etc) have led to the development of new diagnostics test applications, resulting in a phenomenal growth of the IVD market. The adoption of these diagnostics tests has eliminated the need for certain cumbersome traditional diagnostic procedures. Moreover, health awareness among people has increased with the availability of better medical and health (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FE%1Cuyz DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/dc3297/_medical_devices_m) has announced the addition of the " Medical Devices Market in Russia 2009-2013" report to their offering. Medical devices comprise surgical equipment & appliances, diagnostic devices, X-ray, ophthalmic equipment, laboratory devices & diagnostics, dental equipment, medical disposables and others. The Russian Medical devices market is experiencing changes in healthcare standards, which has increased the demand for latest technological medical devices. The healthcare sector in Russia is aiming to strengthen the primary healthcare so as to improve the quality of care and (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FE%1Cu%7Cy DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/1bb0fb/global_immunodiagn) has announced the addition of the "Global ImmunoDiagnostics Market 2009-2013" report to their offering. Immunodiagnostics is a class of diagnostics tests that utilizes antigen-antibody reaction for the detection of diseases. The Clinical Diagnostics market is one of the fastest growing sectors of the healthcare industry. The advancement in various technologies ( biomolecular, genomic, etc) and the emergence of novel technologies are rapidly changing the diagnostics market. Further, the market has been witnessing greater importance in the emerging sectors like genetic testing (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FE%1Cu%7F%7D DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/9b6e13/global_neuromodula) has announced the addition of the "Global Neuromodulation Market 2009-2013" report to their offering. Neuromodulation consist of devices, which are implantable, wireless controlled and delivers electrical current at targeted nerve fibers, to treat a patient's disabling neurological condition. It addresses the needs of the various neurological disorders, nervous system ailments and psychiatric illnesses. It is widely used for the treatment of chronic conditions such as lower back pain, urinary incontinence, Parkinson's disease, tremor, epilepsy, depression, etc. Advancement (…) text/html http://www.biospace.com BioSpace http://www.lsis.com/goto/v93/%3B%97f%FE%12ywr NEW YORK June 11 (Reuters) - A U.S. Congressional committee investigating the recent recall of Johnson & Johnson's (JNJ.N) children's medicine is "deeply concerned" about the manufacturer's cooperation, a committee spokeswoman said on Friday. text/html http://www.marketwire.com Marketwire http://www.lsis.com/goto/v93/%3B%97f%FE%12y%7C%7F Highlighted Links ValueTrak Product Information ValueCentric Home Page ORCHARD PARK, NY-(Marketwire - June 9, 2010) - More than 100 pharmaceutical manufacturers gathered in Marco Island, Florida, for the annual ValueCentric User Conference. Actual, accurate and actionable data was the theme this year as ValueCentric showcased their ability to integrate Trade Channel and Prescription data in one application, an industry first! "As the industry continues to face challenges with projected or estimated data, we now have the ability to deliver actual prescription data that is integrated directly with direct trade channel data, providing a view from shipments into the supply chain through (…) text/html http://www.medicalnewstoday.com Medical News Today http://www.lsis.com/goto/v93/%3B%97f%FE%12%7Eyy Six of Canada's top emerging health care professionals will be recognized with The Robert Wood Johnson Award at a special awards ceremony, held as part of the National Healthcare Leadership Conference. The award supported by Johnson & Johnson Medical Products (JJMP), a division of Johnson & Johnson, recognizes new and emerging leadership. The award provides a platform for and recognizes ongoing development in health services management in communities across Canada. Since its inception in 1956, the award has been presented to 259 Canadian health care professionals. The Robert Wood Johnson Award is bestowed annually through six participating Canadian universities that offer a Masters program (…) text/html http://www.medicalnewstoday.com Medical News Today http://www.lsis.com/goto/v93/%3B%97f%FE%12%7Exz The nonprofit International Partnership for Microbicides (IPM) announced the initiation of the first trial among women in Africa testing a vaginal ring containing an antiretroviral drug (ARV) that could one day be used to prevent HIV transmission during sex. The clinical trial, known as IPM 015, tests the safety and acceptability of an innovative approach that adapts a successful technology from the reproductive health field to give women around the world a tool to protect themselves from HIV infection. "Vaginal rings, commonly used in Europe and the U.S. for hormone delivery, could be well-suited to deliver HIV prevention drugs for women in developing countries," said Dr. Zeda Rosenberg, (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FE%12%7Cwr CARY, N.C.-(BUSINESS WIRE)-Goodmans Interior Structures and Shore Memorial Hospital have received CEO Cancer Gold Standard ¢ accreditation, recognizing commitment of these organizations to taking concrete actions to reduce the cancer risk of employees and their families through screenings, early detection, and healthy changes in lifestyle. do something bold and venturesome about cancer within your own corporate families. William C. Weldon, chairman and chief executive officer of Johnson & Johnson, chairs the CEO Roundtable on Cancer, a nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard ¢, in collaboration with the National Cancer Institute, many of (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FE%12%7C%7Cs DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/9cf77d/endovascular_thora) has announced the addition of the "Endovascular Thoracic Aortic Aneurysm Repair Device Market 2010 Edition - Technology Update & Market Forecast" report to their offering. Endovascular Thoracic Aortic Aneurysm Repair Device Market 2010 Edition - Technology Update & Market Forecast By the end of 2009 the global market for Endovascular Thoracic Aortic Aneurysm & Dissection Repair Devices was estimated at $210 million, a growth rate of 30% over its 2008 level of $160 million. The market is relatively new and is currently driven by new device approvals in key markets. Over the (…) text/html http://www.businesswire.com Business Wire http://www.lsis.com/goto/v93/%3B%97f%FE%13uy%7C SHEFFIELD, England-(BUSINESS WIRE)-Simcyp Limited today announces that it has released the latest version of its flagship simulator, further cementing its position as the industry leader in modelling and simulation of drug-drug interactions (DDIs) in virtual populations. The enhanced features in Version 10.0 of the Simcyp Population-based ADME Simulator have been implemented in accordance with the priorities set by the leading pharmaceutical companies which make up the Simcyp Consortium. The new developments expand Simcyp s DDI capabilities to include transporter interactions and provide the flexibility to use clinical inputs in DDI predictions. This is in line with many of the recent (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v93/%3B%97f%FE%10%7Fz%7E BACKGROUND: Laparoscopic cholecystectomy is the "gold standard" in the treatment of symptomatic gallbladder lithiasis. Nevertheless, some pitfalls are associated with the use of the monopolar hook, such as the risk of thermal injuries and biliary complications. By contrast, the ultrasonically activated scalpel, ie, Harmonic (Ethicon Endo Surgery INC - Johnson & Johnson Medical SPA, Somerville, NJ) in laparoscopic cholecystectomies has been increasingly used for dissection of the gallbladder and for division of vessels and the cystic duct, because it reduces the risk of thermal injuries. METHODS: During a 2-year period, in a personal series of 95 consecutive patients, the Harmonic scalpel (…) text/html http://www.ncbi.nlm.nih.gov NCBI PubMed http://www.lsis.com/goto/v93/%3B%97f%FE%11z%7Cz Background and Objectives: Oral risperidone is licensed globally for the treatment of several psychiatric disorders in children, adolescents and adults. The pharmacokinetic profile of risperidone is well documented in adults. In this study, the pharmacokinetics of oral risperidone in children and adolescents were investigated along with population pharmacokinetics in paediatric and adult subjects. Methods: The pharmacokinetics of oral risperidone in children and adolescents were investigated through non-compartmental analysis (paediatric phase I study; n = 24) and population pharmacokinetic analysis using nonlinear mixed-effects modelling software (NONMEM(R) on a pooled database including (…)